Medication info
DuoRovan Tablets 10/10 mg (Ezetimibe (Unrefined), Rosuvastatin Calcium)

DuoRovan Tablets 10/10 mg (Ezetimibe (Unrefined), Rosuvastatin Calcium)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›10.4mg / 1 tablet
Manufacturer / importer
Kyungdong Pharm. Co., Ltd.
Appearance
White to almost white round film-coated tablets
Packaging
Alu-Alu - 30 tablets/box [(10 tablets/Alu-Alu×3)], Bottle - 30 tablets/bottle
Approval status
Active

MFDS item code 201601223 · Approved 2016.02.29 · Insurance code 648103750

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience.

Ingredients

Manufacturer
Kyungdong Pharm. Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • elevated total cholesterol
  • elevated LDL-cholesterol
  • elevated Apo B protein
  • elevated triglycerides
  • elevated non-HDL-cholesterol
View approved original text

This medication is used as an adjunct to a diet to lower blood levels of total cholesterol, LDL-cholesterol, Apo B protein, triglycerides, and non-HDL-cholesterol in patients with primary hypercholesterolemia, particularly heterozygous familial and non-familial, and mixed dyslipidemia. It should be given along with lipid regulating medications to patients at high risk for atherosclerotic vascular disease due to hypercholesterolemia when diet alone is insufficient. It is important to identify and treat secondary causes of dyslipidemia such as diabetes and hypothyroidism before starting this medication, and to regularly check blood lipid levels before and during treatment. By managing in this way, it helps effectively control blood lipids and reduce the risk of cardiovascular disease.

How to take

Adult dose

This medicine is administered once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment target, and response. Primary hypercholesterolemia The dose range is 10/5mg to 10/20mg once daily. The recommended initial dose is 10/5mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a fixed-dose combination with the same amounts of each active ingredient) for convenience.

Precautions

This medication can rarely cause rhabdomyolysis, which can lead to serious muscle damage, so patients should notify their doctor immediately if they experience muscle pain or weakness symptoms. In particular, if there are risk factors such as severe infections, hypotension, major surgery or trauma, severe metabolic disorders, it may be necessary to temporarily discontinue or stop the use of this medication. Individuals allergic to any ingredient of this medication, those with severe liver impairment, those with muscle diseases, those with severe renal impairment, and women who are pregnant or breastfeeding should not take this medication. Additionally, when taken with certain medications, the risk of side effects may increase; therefore, patients taking other medications should consult with healthcare professionals. This drug may affect liver function; thus, individuals with a history of liver disease or who consume alcohol heavily should undergo regular liver function tests, and treatment should be stopped immediately if symptoms of liver damage appear. Elderly patients or those at risk of myopathy need to be especially cautious when taking this medication and should be advised to undergo muscle-related testing before and during use. Women of childbearing potential should practice adequate contraception while taking this medication and should stop taking it immediately if pregnancy is confirmed. Safety in pediatric or adolescent patients has not been sufficiently established; therefore, it is not recommended for pediatric patients. In case of overdose, there is no specific antidote, so treatment should be symptomatic while monitoring liver function and muscle enzyme tests.

Side effects

nasopharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory infection, chest pain, facial edema, strange sensation, drug intolerance, colorectal polyps, irritable bowel syndrome, esophagitis, drowsiness, neurodegenerative disorder, positional dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, elevated blood cholesterol, increased serum alkaline phosphatase, arrhythmia, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, sweating, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory disorders, pelvic pain, breast cyst, eyelid drooping, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, polyneuropathy, amnesia, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, lupus syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disturbances, interstitial lung disease, sexual dysfunction, gynecomastia, fatal liver failure, non-fatal liver failure, cognitive impairment, myopathy, rhabdomyolysis, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, asthenia, tremors, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, anemia, splenomegaly, conjunctival congestion, renal failure, liver function abnormalities, increased serum creatinine, hypertension, elevated serum urea, increased CPK, abnormal liver function tests, myopathy, myositis, myalgia, muscle weakness, muscle cramps, arthralgia, fatigue, numbness, dysesthesia, chest discomfort, anorexia, abdominal bloating, syncope, generalized pain, gout, erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and should be kept at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the effectiveness and safety of the medication.

Appearance and packaging

Appearance

White to almost white round film-coated tablets

Package unit

Alu-Alu - 30 tablets/box [(10 tablets/Alu-Alu×3)], Bottle - 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.